GLOPID-R

Current state of affairs on Zika, Yellow Fever and other diseases

Discussions at the 2017 GloPID-R General Assembly focused on the lessons learned from responding to infectious diseases such as the Zika virus, yellow fever, MERS CoV and the avian influenza.

Credit: Maurizio De Angelis, Wellcome Images; Wellcome Library, London
Credit: Maurizio De Angelis, Wellcome Images; Wellcome Library, London

Some of the key takeaways include:

Zika Virus

Based on the successful 2016 Zika Virus Research Workshop, participants agreed that a new research workshop should be organized near the end of 2017 to evaluate the impact of funded projects and the effectiveness of coordination efforts.

Yellow Fever

GloPID-R supports ongoing work to evaluate the impact of fractional dosing. Its yellow fever working group will complete discussions in progress and may propose new projects in 2017.

MERS CoV and Avian Influenza

Eung-Soo Hwang, GloPID-R Vice Chair, and Youngmee Jee (National Institute of Health, Korea Centers for Disease Control and Prevention) discussed MERS CoV and Avian influenza, as well as current epidemic threats in Korea and Asia. They presented on cultural challenges, lessons learned and the related public policies set up to respond to emergencies. GloPID-R members agreed to share information on their current activities on influenza.

EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874667.